drugset / Trial / NCT00939952
Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis
Phase 4
Completed
7 enrolled
Albany College of Pharmacy and Health Sciences
Merck Sharp & Dohme LLC · collab
Non-randomizedSingle-groupOpen-label
Summary
The objective of this study is to characterize the pharmacokinetic profile of ertapenem during continuous ambulatory peritoneal dialysis (CAPD).
Timeline
- Start
- 2009-06
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ertapenem | Small molecule | 500 mg | Intravenous |